TRANSACT TECHNOLOGIES INCORPORATED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (In thousands, except share data) (USD $)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Period End Date at Dec. 31, 2011	$ 108,000	$ 25,058,000	$ 21,613,000	$ (11,395,000)	$ (71,000)	$ 35,313,000
Period End Date (in Shares) at Dec. 31, 2011	9,390,262
Issuance of shares from exercise of stock options USD	1,000	171,000				172,000
Issuance of shares from exercise of stock options (in Shares)	51,122
Issuance of deferred stock units		134,000				134,000
Tax benefit (charge) related to employee stock sales and vesting of restricted stock		57,000				57,000
Purchase of treasury stock				(5,938,000)		(5,938,000)
Purchase of treasury stock shares (in Shares)	(721,184)
			(526,000)			(526,000)
Share-based compensation expense		520,000				520,000
Foreign currency translation adj., net of tax					16,000	16,000
Net income			3,621,000			3,621,000
Period End Date at Dec. 31, 2012	109,000	25,940,000	24,708,000	(17,333,000)	(55,000)	33,369,000
Period End Date (in Shares) at Dec. 31, 2012	8,720,200
Issuance of shares from exercise of stock options USD	2,000	1,043,000				1,045,000
Issuance of shares from exercise of stock options (in Shares)	196,358
Issuance of deferred stock units		139,000				139,000
Reversal of deferred tax asset in connection with stock options forfeited		(28,000)				(28,000)
Reversal of deferred tax asset in connection with stock options forfeited (in Shares)	6,919
Tax benefit (charge) related to employee stock sales and vesting of restricted stock		132,000				132,000
Purchase of treasury stock				(5,194,000)		(5,194,000)
Purchase of treasury stock shares (in Shares)	(604,161)
			(2,317,000)			(2,317,000)
Share-based compensation expense		521,000				521,000
Reversal of deferred tax asset in connection with stock options forfeited		(73,000)				(73,000)
Foreign currency translation adj., net of tax					(8,000)	(8,000)
Net income			4,935,000			4,935,000
Period End Date at Dec. 31, 2013	111,000	27,674,000	27,326,000	(22,527,000)	(63,000)	32,521,000
Period End Date (in Shares) at Dec. 31, 2013	8,319,316					11,106,354
Issuance of shares from exercise of stock options USD		13,000				13,000
Issuance of shares from exercise of stock options (in Shares)	6,000
Issuance of deferred stock units		100,000				100,000
Reversal of deferred tax asset in connection with stock options forfeited		(44,000)				(44,000)
Reversal of deferred tax asset in connection with stock options forfeited (in Shares)	9,939
Tax benefit (charge) related to employee stock sales and vesting of restricted stock		7,000				7,000
Purchase of treasury stock				(2,634,000)		(2,634,000)
Purchase of treasury stock shares (in Shares)	(434,998)
			(2,556,000)			(2,556,000)
Share-based compensation expense		506,000				506,000
Reversal of deferred tax asset in connection with stock options forfeited		(89,000)				(89,000)
Foreign currency translation adj., net of tax					(9,000)	(9,000)
Net income			(2,421,000)			(2,421,000)
Period End Date at Dec. 31, 2014	$ 111,000	$ 28,167,000	$ 22,349,000	$ (25,161,000)	$ (72,000)	$ 25,394,000
Period End Date (in Shares) at Dec. 31, 2014	7,900,257					11,122,293